Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 794 of 1,261

  1. US 8828725

    Culture medium

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  2. US 8828448

    Decellularisation of tissue matrices for bladder implantation

    Tissue Regenix Limited · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  3. US 8828399

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  4. US 8829204

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  5. US 8829174

    HCV vaccines and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  6. US 8829187

    Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

    Northwestern University · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  7. US 8829030

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  8. US 8829025

    Anti-cancer compounds

    Northwestern University · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  9. US 8829043

    Oligome-cannabinoid conjugates

    Nektar Therapeutics · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  10. US 8829022

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  11. US 8829008

    Organic compounds

    Takeda Pharmaceutical Company Limited · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  12. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  13. US 8822221

    Targeted integration into the PPP1R12C locus

    Sangamo Biosciences, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  14. US 8822522

    Dual-acting pyrazole antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  15. US 8822470

    Substituted pyrido[2,3-b]pyrazines

    Takeda Pharmaceutical Company Limited · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  16. US 8822489

    Abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  17. US 8822540

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  18. US 8822548

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  19. US 8822681

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  20. US 8822469

    Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  21. US 8822196

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  22. US 8821850

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  23. US 8821880

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    China Synthetic Rubber Corporation · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  24. US 8821884

    Compositions and methods using MD-2 mutants and chimeric proteins

    The Regents of the University of California · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.